Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Israel

Harel 4B Selected Biomed

+ Add to Watchlist

IL30EQY:IT

2,951.57 ILs 8.38 0.28%

As of 00:59:30 ET on 01/29/2015.

Snapshot for Harel 4B Selected Biomed (IL30EQY)

Year To Date: +10.06% 3-Month: +6.35% 3-Year: -0.97% 52-Week Range: 2,540.33 - 4,971.44
1-Month: +10.06% 1-Year: -34.59% 5-Year: -6.85% Beta vs TA-100: 0.91

Mutual Fund Chart for IL30EQY

No chart data available.
  • IL30EQY:IT 2,951.57
  • 1M
  • 1Y
Interactive IL30EQY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IL30EQY

Harel 4B Selected Biomed is an open-end fund registered in Israel. The objective of the fund is to exceed to TA Biomed Index. The fund primarly invests in Biotechnology and Pharmaceutical equities.

Inception Date: 01-01-1993 Telephone: -
Managers: -
Web Site: -

Fundamentals for IL30EQY

NAV (on 2015-01-29) 2,951.57
Assets (M) (on 2014-12-31) 17.50
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for IL30EQY

No dividends reported

Fees & Expenses for IL30EQY

Front Load -
Back Load -
Current Mgmt Fee 2.51
Redemption Fee -
12b1 Fee -
Expense Ratio 2.94

Top Fund Holdings for IL30EQY

Filing Date: 08/31/2014
Name Position Value % of Total
Compugen Ltd 85,000 2,701,300 9.609%
Evogene Ltd 55,951 2,582,139 9.185%
Mazor Robotics Ltd 93,000 2,288,730 8.141%
Clal Biotechnology Industries 245,001 2,046,244 7.279%
Kamada Ltd 84,000 2,037,000 7.246%
Pluristem Therapeutics Inc 190,000 1,859,720 6.615%
Protalix BioTherapeutics Inc 190,000 1,744,200 6.204%
Brainsway Ltd 36,000 1,511,640 5.377%
Elron Electronic Industries Lt 37,000 1,173,270 4.174%
SPDR S&P Biotech ETF 1,800 1,040,108 3.700%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil